RT Journal Article
SR Electronic
T1 Cohort profile: OpenPROMPT
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.12.21.23300369
DO 10.1101/2023.12.21.23300369
A1 Henderson, Alasdair D
A1 Carlile, Oliver
A1 Dillingham, Iain
A1 Butler-Cole, Ben FC
A1 Tomlin, Keith
A1 Jit, Mark
A1 Tomlinson, Laurie A
A1 Marks, Michael
A1 Briggs, Andrew
A1 Lin, Liang-Yu
A1 Bates, Chris
A1 Parry, John
A1 Bacon, Sebastian CJ
A1 Goldacre, Ben
A1 Mehrkar, Amir
A1 The OpenSAFELY Collaborative
A1 Herrett, Emily
A1 Eggo, Rosalind M
YR 2023
UL http://medrxiv.org/content/early/2023/12/24/2023.12.21.23300369.abstract
AB OpenPROMPT is a cohort of individuals with longitudinal patient reported questionnaire data and linked to routinely collected health data from primary and secondary care. Data were collected between November 2022 and October 2023 in England. OpenPROMPT was designed to measure the impact of long COVID on health-related quality-of-life (HRQoL). With the approval of NHS England we collected responses from 7,574 individuals, with detailed questionnaire responses from 6,337 individuals who responded using a smartphone app. Data were collected from each participant over 90 days at 30-day intervals using questionnaires to ask about HRQoL, productivity and symptoms of long COVID. Responses from the majority of OpenPROMPT (6,006; 79.3%) were linked to participants’ existing health records from primary care, secondary care, COVID-19 testing and vaccination data. Analysis takes place using the OpenSAFELY data analysis platform which provides a secure software interface allowing the analysis of pseudonymized primary care patient records from England. OpenPROMPT can currently be used to estimate the impact of long COVID on HRQoL, and because of the linkage within OpenSAFELY, the data from OpenPROMPT can be used to enrich routinely collected records in further research by approved researchers on behalf of NHS England.Lay summary OpenPROMPT is a study which used a phone app to conduct a longitudinal survey aimed at measuring the health related quality of life of people living with long COVID. The study recruited participants between November 2022 and July 2023 and followed them up for 90 days. The key advantage of this study is that the responses are linked to the individual’s personal health records, so we have access to much more data than the questionnaire responses alone.Here, we summarised who has used the app, how much data has been collected and the quality of the data. We also provide details to document how and why the data were collected so that the data can be used by other researchers in the future. This will maximise the benefit of this study, and ensure that the time invested by participants is put to best use.In this study we aimed to provide lots of important information about how many people are involved, how much information we have about them, their age, where they live, and how healthy they are. Finally, for certain variables we compared the responses people recorded in the app with what is kept on their electronic record to see if they agree or disagree.Key featuresOpenPROMPT is a cohort of individuals with longitudinal patient reported questionnaire data and linked to routinely collected health data from primary and secondary care.With the approval of NHS England we collected responses from 7,574 individuals, with detailed questionnaire responses from 6,337 individuals who responded using a smartphone app.Data were collected from each participant over 90 days at 30-day intervals using questionnaires to ask about HRQoL, productivity and symptoms of long COVID.Responses from the majority of OpenPROMPT (6,006; 79.3%) were linked to participants’ existing health records from primary care, secondary care, COVID-19 testing and vaccination data.OpenPROMPT can currently be used to estimate the impact of long COVID on HRQoL, and because of the linkage within OpenSAFELY, the data from OpenPROMPT can be used to enrich routinely collected records in further research by approved researchers on behalf of NHS England.Competing Interest StatementBG and OpenSAFELY has received research funding from the Laura and John Arnold Foundation, the NHS National Institute for Health Research (NIHR), the NIHR School of Primary Care Research, NHS England, the NIHR Oxford Biomedical Research Centre, the Mohn-Westlake Foundation, NIHR Applied Research Collaboration Oxford and Thames Valley, the Wellcome Trust, the Good Thinking Foundation, Health Data Research UK, the Health Foundation, the World Health Organisation, UKRI MRC, Asthma UK, the British Lung Foundation, and the Longitudinal Health and Wellbeing strand of the National Core Studies programme; he is a Non-Executive Director at NHS Digital; he also receives personal income from speaking and writing for lay audiences on the misuse of science. AM has received consultancy fees (from https://inductionhealthcare.com) and is member of RCGP health informatics group and the NHS Digital GP data Professional Advisory Group that advises on access to GP Data for Pandemic Planning and Research (GDPPR). For the latter, he received payment for the GDPPR role.Funding StatementThis research was supported by the National Institute for Health and Care Research (NIHR) (OpenPROMPT: COV-LT2-0073)). The OpenSAFELY Platform is supported by grants from the Wellcome Trust (222097/Z/20/Z) and MRC (MR/V015737/1, MC_PC_20059, MR/W016729/1). In addition, development of OpenSAFELY has been funded by the Longitudinal Health and Wellbeing strand of the National Core Studies programme (MC_PC_20030: MC_PC_20059), the NIHR funded CONVALESCENCE programme (COV-LT-0009), NIHR (NIHR135559, COV-LT2-0073), and the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant ref MC_PC_20058) and Health Data Research UK (HDRUK2021.000). The views expressed are those of the authors and not necessarily those of the NIHR, NHS England, UK Health Security Agency (UKHSA) or the Department of Health and Social Care. Funders had no role in the study design, collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research is part of the OpenPROMPT study 'Quality-of-life in patients with long COVID: harnessing the scale of big data to quantify the health and economic costs' which has ethical approval from HRA and Health and Care Research Wales (HCRW) (IRAS project ID 304354). The Study Coordination Centre has obtained approval from the LSHTM Research Ethics Committee (ref 28030), as well as a favourable opinion from the South Central-Berkshire B Research Ethics Committee (ref 22/SC/0198).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe OpenPROMPT questionnaire data provided by participants will be made available to allow other researchers to benefit from this work in the future, and for a range of different studies and purposes. Data access will be free, please contact openprompt{at}lshtm.ac.uk. If accessing through OpenSAFELY then access will be subject to completion of data security requirements specified by the OpenSAFELY platform at the time of application. All other study documentation will be stored for a minimum of 5 years after the follow-up period.